Cargando…
Cost-effectiveness of percutaneous coronary intervention versus medical therapy in patients with acute myocardial infarction: real-world and lifetime-horizon data from Taiwan
Although some studies have assessed the cost-effectiveness of percutaneous coronary intervention (PCI) in acute myocardial infarction (AMI), there has been a lack of nationwide real-world studies estimating life expectancy (LE), loss-of-LE, life-years saved, and lifetime medical costs. We evaluated...
Autores principales: | Liao, Chia-Te, Hsieh, Tung-Han, Shih, Chia-Yin, Liu, Ping-Yen, Wang, Jung-Der |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7947011/ https://www.ncbi.nlm.nih.gov/pubmed/33692425 http://dx.doi.org/10.1038/s41598-021-84853-y |
Ejemplares similares
-
Real-world cost-effectiveness of denosumab for the treatment of postmenopausal osteoporosis in Taiwan
por: Johnson, Ben, et al.
Publicado: (2021) -
New Horizons of Acute Myocardial Infarction: From the Korea Acute Myocardial Infarction Registry
por: Lee, Ki Hong, et al.
Publicado: (2013) -
Lifetime risks, expected years of life lost, and cost-per-life year of esophageal cancer in Taiwan
por: Lai, Wu-Wei, et al.
Publicado: (2020) -
Influence of the Coronavirus Disease 2019 Pandemic on Patients with ST-Segment Elevation Myocardial Infarction in Taiwan
por: Su, Yuan-Heng, et al.
Publicado: (2021) -
Real-world efficacy and safety of pangenotypic direct-acting antivirals against hepatitis C virus infection in Taiwan
por: Chang, Kao-Chi, et al.
Publicado: (2021)